Pfizer Admits Defeat for Now: Kulhoff

Pfizer Admits Defeat for Now: Kulhoff Play

May 26 (Bloomberg) -- Birgit Kulhoff, Heath Care Analyst at Rahn & Bodmer, discusses the likelihood of a deal between Pfizer and AstraZeneca, and what that may mean for cancer, diabetes, and auto immune disease drugs. She speaks on Bloomberg Television's “The Pulse.” (Source: Bloomberg)

  • On Air Now

    The Pulse Watch Now

  • Next

    Bloomberg Surveillance

blog comments powered by Disqus